DE3575923D1 - Auf das zentralnervensystem wirksame thiadiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. - Google Patents

Auf das zentralnervensystem wirksame thiadiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.

Info

Publication number
DE3575923D1
DE3575923D1 DE8585401972T DE3575923T DE3575923D1 DE 3575923 D1 DE3575923 D1 DE 3575923D1 DE 8585401972 T DE8585401972 T DE 8585401972T DE 3575923 T DE3575923 T DE 3575923T DE 3575923 D1 DE3575923 D1 DE 3575923D1
Authority
DE
Germany
Prior art keywords
group
derivatives
production
ventilation system
products containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585401972T
Other languages
German (de)
English (en)
Inventor
Roger Brodin
Camille Georges Wermuth
Paul Worms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3575923D1 publication Critical patent/DE3575923D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
DE8585401972T 1984-10-18 1985-10-10 Auf das zentralnervensystem wirksame thiadiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. Expired - Fee Related DE3575923D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8415991A FR2572074B1 (fr) 1984-10-18 1984-10-18 Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DE3575923D1 true DE3575923D1 (de) 1990-03-15

Family

ID=9308790

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585401972T Expired - Fee Related DE3575923D1 (de) 1984-10-18 1985-10-10 Auf das zentralnervensystem wirksame thiadiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.

Country Status (16)

Country Link
US (1) US4596802A (US20040106767A1-20040603-C00005.png)
EP (1) EP0183577B1 (US20040106767A1-20040603-C00005.png)
JP (1) JPS6197274A (US20040106767A1-20040603-C00005.png)
KR (1) KR860003245A (US20040106767A1-20040603-C00005.png)
AT (1) ATE50253T1 (US20040106767A1-20040603-C00005.png)
AU (1) AU577159B2 (US20040106767A1-20040603-C00005.png)
CA (1) CA1259990A (US20040106767A1-20040603-C00005.png)
DE (1) DE3575923D1 (US20040106767A1-20040603-C00005.png)
DK (1) DK469285A (US20040106767A1-20040603-C00005.png)
ES (1) ES8605269A1 (US20040106767A1-20040603-C00005.png)
FR (1) FR2572074B1 (US20040106767A1-20040603-C00005.png)
GR (1) GR852530B (US20040106767A1-20040603-C00005.png)
IL (1) IL76652A0 (US20040106767A1-20040603-C00005.png)
NZ (1) NZ213865A (US20040106767A1-20040603-C00005.png)
PT (1) PT81314B (US20040106767A1-20040603-C00005.png)
ZA (1) ZA858030B (US20040106767A1-20040603-C00005.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625774D0 (en) * 1986-10-28 1986-12-03 Reckitt & Colmann Prod Ltd Thiadiazole derivative
FR2636628B1 (fr) * 1988-08-25 1990-12-28 Sanofi Sa Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
IT1255219B (it) * 1992-07-14 1995-10-20 Ct Lab Farm Srl Derivati del tiadiazolo per la cura degli stati depressivi
AU2005295441B2 (en) * 2004-10-18 2009-04-23 Amgen, Inc. Thiadiazole compounds and methods of use
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (US20040106767A1-20040603-C00005.png) * 1964-03-26
FR2092714B1 (US20040106767A1-20040603-C00005.png) * 1970-06-11 1974-03-22 Melle Bezons
US3919428A (en) * 1972-01-17 1975-11-11 Sandoz Ag 2-Amino-5-(substituted or unsubstituted phenylalkyl)1,3,4-thiadiazoles for treating anxiety

Also Published As

Publication number Publication date
KR860003245A (ko) 1986-05-21
AU4848085A (en) 1986-04-24
ZA858030B (en) 1986-06-25
AU577159B2 (en) 1988-09-15
FR2572074B1 (fr) 1987-07-17
IL76652A0 (en) 1986-02-28
DK469285D0 (da) 1985-10-14
PT81314A (fr) 1985-11-01
EP0183577A1 (fr) 1986-06-04
PT81314B (pt) 1987-11-30
CA1259990A (en) 1989-09-26
ATE50253T1 (de) 1990-02-15
FR2572074A1 (fr) 1986-04-25
ES547962A0 (es) 1986-03-16
NZ213865A (en) 1988-05-30
JPS6197274A (ja) 1986-05-15
GR852530B (US20040106767A1-20040603-C00005.png) 1986-02-19
DK469285A (da) 1986-04-19
US4596802A (en) 1986-06-24
EP0183577B1 (fr) 1990-02-07
ES8605269A1 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
DE3263734D1 (en) Derivatives of 1-aryl-2-aminomethyl-cyclopropane-carboxamides (z), their preparation and their use as medicines in the treatment of disorders of the central nervous system
ATE130604T1 (de) Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE122009000040I1 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ATE91682T1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ATE9690T1 (de) Amino-substituierte tetrahydrobenzindole, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3575923D1 (de) Auf das zentralnervensystem wirksame thiadiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE3573119D1 (en) 8-alkylthio-2-piperazino-pyrimidoû5,4-d¨pyrimidines, their preparation and medicaments containing them
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE27602T1 (de) Tryptaminderivate mit wirkung auf das kardiovaskulaere system und verfahren zu ihrer herstellung.
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
SE8304715D0 (sv) Neue, acylierte 1,2,4-triazol-derivate, deren intermediare, verfahren zu ihrer herstellung und die 1,2,4-triazol-derivate enthaltende arzneimittelpreparate
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE56012T1 (de) Indolo-(6,5,4-cd)-indol derivate und verfahren zu deren herstellung.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
OA08813A (fr) Nouveaux dérivés de l'acide (dihydro-2,3, oxo-2 benzofurannyl-3)-2 acétique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
DE3262166D1 (en) A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition
ATE82289T1 (de) 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
SE8303720L (sv) Eburnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande desamma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee